DEFLEGMIN chronic bronchitis treatment
- DEFLEGMIN. Acute and chronic diseases of the respiratory tract extending from the obstacle Secretion thick, excessively viscous bronchial secretions, e.g.,. Chronic bronchitis and its exacerbations asthmatic bronchitis.
DEFLEGMIN, chronic bronchitis treatment Composition:
1 tablet contains 30 mg of ambroxol.
lactose, corn starch, colloidal silica, magnesium stearate.
Ambroxol is a metabolite bromheksydyny action mucolytic. Liquefies bronchial secretions and reduces the viscosity of mucus probably on the way depolymerization of macromolecules of acid mucopolysaccharides. As a result, facilitates expectoration, improves patency of the bronchi, soothes kaszel.Zwiększa the frequency of movements of cilia and accelerates the transport muco - ciliary. It stimulates the production of surface-active agent (surfactant) for type II pneumocyte cells and Clara. The surfactant facilitates the separation of the bands viscous mucus from bronchial wall and transportation over the entire length of the bronchial tree, in particular in small without cilia oskrzelach.Surfaktant also stimulates the phagocytic activity of macrophages, protecting the airway epithelium against pathogenic bacteria.
DEFLEGMIN Indications: acute and chronic airway extending secretion of difficulty thick, excessively viscous bronchial secretions, e.g.,. chronic bronchitis and its exacerbations, asthmatic bronchitis, bronchial asthma, bronchiectasis, laryngitis, sinusitis, pre- and postoperative to avoid system-related complications respiratory (especially in elderly patients).
DEFLEGMIN, chronic bronchitis treatment Dosage: Adults: Oral, 3 times a day 1 tablet. In the long-term treatment dose you can be reduced to 2 times daily 1 tablet. The drug should be taken after eating, drinking a small amount of liquid.
Hypersensitivity to ambroxol. The drug should not be used with ulcers of the stomach, duodenum and intestines.